Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Urinary Incontinence 1Nocturnal Enuresis 1Neoplasms 1Diurnal Enuresis 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × mebeverine × Clear all
NCT04635566 2020-11-19

Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute

Mansoura University

Phase NA Completed
120 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Incontinence

NCT03147599 2020-06-30

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Mansoura University

Phase 4 Completed
110 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms, Nocturnal Enuresis, Diurnal Enuresis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡